2EU2

Human Carbonic Anhydrase II in complex with novel inhibitors

2EU2 の概要

• エントリーDOI: 10.2210/pdb2eu2/pdb
• 関連するPDBエントリー: 2EU3
• 分子名称: Carbonic anhydrase 2, ZINC ION, (R)-1-AMINO-1-[5-(DIMETHYLAMINO)-1,3,4-THIADIAZOL-2-YL]METHANESULFONAMIDE, ... (4 entities in total)
• 機能のキーワード: carbonic anhydrase ii proton transfer inhibitor, lyase
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 29591.77

構造登録者

Fisher, S.Z.,Govindasamy, L.,Boyle, N.,Agbandje-McKenna, M.,Silverman, D.N.,Blackburn, G.M.,McKenna, R. (登録日: 2005-10-28, 公開日: 2006-07-11, 最終更新日: 2023-08-23)

主引用文献

Fisher, S.Z.,Govindasamy, L.,Boyle, N.,Agbandje-McKenna, M.,Silverman, D.N.,Blackburn, G.M.,McKenna, R.
X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes.
Acta Crystallogr.,Sect.F, 62:618-622, 2006

PubMed Abstract: Human carbonic anhydrases (CAs) are well studied targets for the development of inhibitors for pharmaceutical applications. The crystal structure of human CA II has been determined in complex with two CA inhibitors (CAIs) containing conventional sulfonamide and thiadiazole moieties separated by a -CF2- or -CHNH2- spacer group. The structures presented here reveal that these spacer groups allow novel binding modes for the thiadiazole moiety compared with conventional CAIs.

PubMed: 16820676
DOI: 10.1107/S1744309106020446

実験手法

X-RAY DIFFRACTION (1.15 Å)